Abivax, a biotechnology company, is beginning an extension study concerning ABX464-102, its ulcerative colitis therapy, to evaluate the drug's safety and efficacy.
GI & Endoscopy
Water recreation in the United States accounts for over 90 million cases of GI and other illnesses per year, with an annual cost of approximately $2.9 billion, according to a study published in Environmental Health.
Wilmington, Ohio-based CMH Regional Health System will acquire Cincinnati-based Southwest Ohio Gastroenterology and Clinton County Outpatient Surgery in Wilmington, effective Feb. 1.
Here are five updates on GI companies from the past week:
A study, published in The American Journal of Gastroenterology, examined what patients value from inflammatory bowel disease biologic medicines.
Advertisement
A study, published in The American Journal of Gastroenterology, examined the efficacy and safety of linaclotide for patients with chronic idiopathic constipation.
A study, published in The American Journal of Gastroenterology, examined the impact depression has on inflammatory bowel disease patients.
Medscape released its "2018 Physician Lifestyle & Happiness Report," compiling physicians' opinions on a wide array of lifestyle choices.
Donnie Smith, MD, is a gastroenterologist at Tuscaloosa-based GI Associates of West Alabama.
On the heels of announcing its preliminary fiscal year 2017 results, Exact Sciences announced plans to ramp up sales and marketing efforts to push the company's flagship product, Cologuard, Xconomy Wisconsin reports.